HerelleX recognized at Santander X Global Awards, MWC 2026
Our CEO, Agustín Pablo Seijo, shares the vision behind FluoTB, the low-cost tuberculosis diagnostic tool we are developing.


The recognition
HerelleX was recognized at the Santander X Global Awards, held during MWC Barcelona 2026.

About FluoTB
We are developing FluoTB, a low-cost diagnostic tool based on engineered mycobacteriophages. Its goal is to make TB detection faster and more accessible, especially in low-resource and high-burden regions.

This recognition reinforces what drives HerelleX: turning cutting-edge research into scalable solutions with global health impact.
Thank you to Santander X for this opportunity and for supporting innovation with purpose.

